in this article consisted of type II malignant thymoma 1 and well-differentiated thymic carcinoma.
We think that well-differentiated thymic carcinoma is distinct from type II malignant thymoma (proper thymic carcinoma) because of differences of some markers (cytokeratins, 4 bcl-2, and Fas antigen 5 ) and associated diseases. Well-differentiated thymic carcinoma has been considered to be epithelium-rich thymoma by most pathologists. It is related to cortical thymoma (Müller-Hermelink) or polygonal cell thymoma (Rosai) and frequently is associated with myasthenia gravis. Designation of well-differentiated thymic carcinoma has caused striking confusion, because it overlaps with well-differentiated squamous cell carcinoma. 6 The latter belongs to the category "proper thymic carcinoma" and constitutes a low-grade category of thymic carcinoma, together with well-differentiated mucoepidermoid carcinoma and basaloid carcinoma. We agree with Suster and Moran's proposal 7 to designate well-differentiated thymic carcinoma as "atypical thymoma." Clinical results of "atypical thymoma," well-differentiated squamous cell carcinoma (low-grade), and other types of thymic carcinoma (high-grade) should be evaluated separately. Although the article by Blumberg and associates revealed no significant difference between survivals of patients with well-differentiated thymic carcinoma and type II malignant thymoma, we expect that an increase in the number of patients and longer observation times may reveal a difference.Patients with proper thymic carcinoma usually have an advanced stage of the disease. Accordingly, it seems almost meaningless to compare results of each stage in patients with proper thymic carcinoma. We think that the TNM classification may be useful in thymic carcinomas. Table I shows the TNM classification system of thymic epithelial tumors, which is revised minimally from the one described in our previous article.
8
T factors mimic the stages. N factors are arranged according to the lymph node stations along the lymphatic route from the thymus. TNM numbers of 5 cases of stage IVb in our series were as follows: T2 N1 M0, T3 N1 M0, T3 N0 M1, T3 N3 M1, and T4 N0 M1. Three cases were N-positive and 3 cases were M-positive. However, evaluation of the N factor was not always complete, especially in the patients from the early period of our study. Therefore N-positive cases might be more frequent than our results indicate. As cases accumulate, this TNM classification system may become more useful.
